Your session is about to expire
← Back to Search
PET Imaging for Blood Clots
Study Summary
This trial is testing a new radiotracer to see if it can detect thrombosis (clots) in the body using PET-MR imaging. This could provide a non-invasive alternative to current methods.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- Your heart rate is consistently too fast (over 120 beats per minute) or too slow (under 50 beats per minute).I've had chest pain recently but underwent a stress test or coronary angiography afterwards.You have been exposed to too much radiation in the past year according to the Radiology Department's guidelines.I am unable to provide written consent.You have a confirmed blood clot shown on an ultrasound or CT scan, or have a high chance of having a blood clot based on a blood test called D-dimer.I have fainted in the last 6 weeks.I cannot lie comfortably in a PET scanner.You stop breathing for more than 3 seconds during the day.I am not pregnant or breastfeeding, confirmed by a negative pregnancy test.I have a history of irregular heartbeats.I experience severe discomfort in confined spaces.You weigh more than the maximum weight allowed for the MRI or CT table.I have not had heart or major surgery in the last 3 months.I had a heart scan in the last 2 weeks and my blood thinner medication hasn't changed since.You have tested positive for COVID-19 using a specific type of test in the past month.You have metal or electric implants that are not safe for MR-PET scanning when needed.I have been diagnosed with cancer.I have not been treated with clot-dissolving drugs.I am under 18 years old.You have an electrical implant like a pacemaker or a pump.I have had a heart attack in the last 3 months.I have not had a stroke in the past 3 months.
- Group 1: Cancer Patients
- Group 2: Other Thrombotic Condition Patients
- Group 3: COVID-19 Patients
- Group 4: Healthy Volunteers
- Group 5: Atrial Fibrillation Patients
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the age criterion for this trial including individuals over 25 years old?
"This clinical trial is open to those aged 18 and over, up until the age of 85."
Has [64Cu]FBP8 received the necessary regulatory approval from the FDA?
"Our company's evaluation of [64Cu]FBP8's safety gave it a score of 1, which is the lowest on this scale. This rating reflects that there is only minimal clinical data available to assess its efficacy and safety profile."
Is my involvement in this experiment permissible?
"This clinical trial requires enrolment of 240 participants between the ages 18 and 85 with thrombus. Furthermore, certain criteria need to be met for prospective enrollment: TEE must be completed in next 14 days; SARS-CoV-2 RNA detected by RT-PCR collected from upper or lower respiratory tract analyzed within last month; patient not requiring mechanical ventilation; diagnosed with cancer; ultrasound or CT confirmed/high likelihood of thrombus (e.g., elevated D-dimer); no prior use of thrombolytics and a history of atrial fibrillation/paroxysmal atrial fibrillation"
Is there still availability for participation in this experiment?
"Affirmative. Clinicaltrials.gov's records reveal that this study, which was launched on August 1st 2016, is actively searching for volunteers to take part in the experiment. A total of 240 subjects are required from one distinct medical centre."
What is the maximum capacity of participants in this trial?
"Affirmative. The information accessible on clinicaltrials.gov states that recruitment for this investigation is ongoing. It was first posted back in August 1st 2016 and the latest update occurred February 3rd 2022, with an aim of enrolling 240 patients at a single site."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger